Summary: “I’m here to say that there is new hope for the treatment of trauma,” begins MAPS Founder Rick Doblin, Ph.D., at the Oslo Freedom Forum in Oslo, Norway, on May 29, 2018. “This hope is coming from a psychedelic drug called MDMA.”
Originally appearing here.
